---
access_model:
  confidence: low
  label: Unknown
  onboarding: unknown
  pricing: unknown
  public: false
  source:
  - authentication
  - rate-limits
  - security
  trial: false
  try_now: false
agent_readiness:
  band: agent-aware
  dimensions:
    agent_card: false
    agent_skills: derived
    agentic_access: false
    agentic_commerce: false
    auth_clarity: bearer
    consent_identity: false
    delegated_identity: false
    dry_run_mode: false
    dynamic_client_registration: false
    error_semantics: derived
    event_surface_described: false
    idempotency: false
    mcp_server: false
    mcp_tool_quality: na
    openapi_examples: false
    operation_distinctiveness: na
    pagination_ratio: na
    protected_resource_metadata: false
    rate_limit_signal: documented
    reversibility_documented: false
    spec_presence: false
    well_known_catalog: false
  schema_version: '0.2'
  score: 6.7
  scored_at: '2026-11-06'
api_count: 2
apis:
- description: 'The public WordPress REST API (wp-json) of the Nura Bio website at nurabio.com: the route index of the site''s content management system, catalogued as one site surface rather than as separate APIs.'
  name: Nura Bio Website (WordPress REST)
  slug: nurabio-com-website-wordpress-rest
artifact_total: 8
common:
- group: company
  title: ''
  type: Website
  url: https://nurabio.com/
- group: company
  title: ''
  type: About
  url: https://nurabio.com/about-us/
- group: other
  title: ''
  type: Science
  url: https://nurabio.com/our-science/
- group: company
  title: ''
  type: News
  url: https://nurabio.com/news-and-literature/
- group: company
  title: ''
  type: BlogRSS
  url: https://nurabio.com/feed/
- group: company
  title: ''
  type: Careers
  url: https://nurabio.com/join-us/
- group: operate
  title: ''
  type: ContactForm
  url: https://nurabio.com/contact/
- group: company
  title: ''
  type: LinkedIn
  url: https://www.linkedin.com/company/nurabio
- group: agent
  href: https://artifacts.apis.io/nura-bio/llms/nura-bio-llms.txt
  title: ''
  type: LLMsTxt
  url: llms/nura-bio-llms.txt
- group: auth
  href: https://artifacts.apis.io/nura-bio/authentication/nura-bio-authentication.yml
  title: ''
  type: Authentication
  url: authentication/nura-bio-authentication.yml
- group: design
  href: https://artifacts.apis.io/nura-bio/conventions/nura-bio-conventions.yml
  title: ''
  type: Conventions
  url: conventions/nura-bio-conventions.yml
- group: design
  href: https://artifacts.apis.io/nura-bio/conformance/nura-bio-conformance.yml
  title: ''
  type: Conformance
  url: conformance/nura-bio-conformance.yml
- group: design
  href: https://artifacts.apis.io/nura-bio/errors/nura-bio-problem-types.yml
  title: ''
  type: ErrorCatalog
  url: errors/nura-bio-problem-types.yml
- group: design
  href: https://artifacts.apis.io/nura-bio/lifecycle/nura-bio-lifecycle.yml
  title: ''
  type: Lifecycle
  url: lifecycle/nura-bio-lifecycle.yml
- group: design
  href: https://artifacts.apis.io/nura-bio/data-model/nura-bio-data-model.yml
  title: ''
  type: DataModel
  url: data-model/nura-bio-data-model.yml
- group: operate
  href: https://artifacts.apis.io/nura-bio/rate-limits/nura-bio-rate-limits.yml
  title: ''
  type: RateLimits
  url: rate-limits/nura-bio-rate-limits.yml
- group: commercial
  href: https://artifacts.apis.io/nura-bio/plans/nura-bio-plans-pricing.yml
  title: ''
  type: Plans
  url: plans/nura-bio-plans-pricing.yml
- group: build
  href: https://artifacts.apis.io/nura-bio/packages/nura-bio-packages.yml
  title: ''
  type: Packages
  url: packages/nura-bio-packages.yml
- group: auth
  href: https://artifacts.apis.io/nura-bio/security/nura-bio-domain-security.yml
  title: ''
  type: DomainSecurity
  url: security/nura-bio-domain-security.yml
- group: agent
  href: https://artifacts.apis.io/nura-bio/skills/_index.yml
  title: ''
  type: AgentSkill
  url: skills/_index.yml
created: '2026-08-26'
description: Nura Bio, Inc. is a clinical-stage biopharmaceutical company headquartered in South San Francisco, California, developing neuroprotective small-molecule medicines that halt neurodegeneration before it progresses. Conceived in 2018 by The Column Group together with scientific founders Steve McKnight, PhD and Marc Freeman, PhD, the company targets SARM1 — a neuronally enriched NAD hydrolase that acts as an axon-intrinsic metabolic sensor and central driver of axonal degeneration — on the thesis that intervening early in that pathway confers durable structural and functional neuroprotection across peripheral, central and ocular nervous-system disorders. Its pipeline is led by NB-4746, a first-generation oral, brain-penetrant, reversible orthosteric SARM1 inhibitor in a global Phase 1b/2a study in ALS, and NB-9402, a mechanistically differentiated second-generation oral, covalent, irreversible, allosteric inhibitor completing a Phase 1a healthy-volunteer study in 2026. Nura Bio
  launched publicly in January 2020 with a $73 million Series A, extended that round with $68 million to pass $140 million raised, and closed a $73.8 million Series B in June 2026 led by The Column Group with Euclidean Capital, Samsara BioCapital and Sanofi Ventures; Shilpa Sambashivan, PhD, a co-founder and its chief scientist, serves as CEO. Its science is published in NEURON and CELL REPORTS. Nura Bio runs no developer program and publishes no product API, developer portal, API reference, SDK or pricing. The only machine-readable surfaces reachable without credentials are a published llms.txt and the WordPress REST content API behind nurabio.com, which serves the news archive, site pages, people directory and media library as JSON — both catalogued here.
image: https://nurabio.com/wp-content/uploads/2020/07/NuraBio_full_logo_grey_TM-1-1-1030x167.png
layout: provider
modified: '2026-08-26'
name: Nura Bio
nav: Providers
network: true
overview: 'Nura Bio publishes 1 API contract indexed on the [APIs.io](https://apis.io/) network. Tagged areas include Company, Biotechnology, Pharmaceuticals, Neuroscience, and Neurodegeneration.


  Nura Bio''s developer surface includes product news, authentication, and 18 more developer resources.'
plans:
- name: Nura Bio Plans Pricing
  plan_count: 0
  slug: nura-bio-plans-pricing
random_paper: 5
rate_limits:
- limit_count: 0
  name: Nura Bio Rate Limits
  slug: nura-bio-rate-limits
score:
  band: emerging
  composite: 11.6
  coverage:
    artifact_dirs: 20
    catalog_earned: 32.0
    catalog_earned_first_party: 0.0
    catalog_gap: 83.0
    catalog_max: 115.0
    note: 'Disclosure, not a penalty. catalog_gap is rubric points API Evangelist could add with no action by this provider, and it is NOT subtracted from the composite above. It is our backlog EXCEPT where this provider already did the work: catalog_earned is how much of the class was satisfied at all, and catalog_earned_first_party how much of that came from artifacts the provider published rather than ones we generated (roadmap#221). catalog_earned_first_party is a FLOOR, not the whole share: only ~40 of the rubric''s 113 checks carry a provenance class at all, so a check we cannot attribute counts toward neither side. Read it as "at least this much was theirs", never as "the rest was ours".'
  delta: -1.0
  facets:
    access_clarity: 0.0
    contract_governance: 4.5
    contract_quality: 0.0
    developer_ergonomics: 18.5
    discoverability: 65.2
    operational_transparency: 0.0
  jurisdiction:
    basis: provider tags (build_countries.py / build_regions.py)
    countries:
    - united-states
    note: A first approximation of where this provider operates, derived from the tags on its profile. NOT a legal determination of domicile or regulatory scope, and it does not yet decide which regimes the regulatory facet evaluates (roadmap#85).
    regions:
    - north-america
  previous_composite: 12.6
  provenance:
    conformance: derived
    mcp: derived
    skills: derived
  regulatory:
    applies: true
    matched_via: tags
    regime: Health
    regime_id: health
    score: 18.0
  schema_version: 0.27.0
  scored_at: '2026-11-06'
  trend: flat
  upsert:
    applies: false
    note: 'Not scored: this provider''s published contracts declare no write operations, and a read-only API cannot create-or-update. Excluded from the denominator, not zeroed.'
    reason: read_only
screenshot: https://apis.io/screenshots/nura-bio/nura-bio-2026-09-02T150816.png
security:
- kind: authentication
  name: Nura Bio Authentication
  slug: nura-bio-authentication
  summary_line: 2 schemes
- kind: domain-security
  name: Nura Bio Domain Security
  slug: nura-bio-domain-security
  summary_line: TLSv1.3 · DMARC
skill_count: 3
skills:
- name: nura-bio-resolve-people-directory
  slug: nura-bio-resolve-people-directory
- name: nura-bio-search-and-resolve-content
  slug: nura-bio-search-and-resolve-content
- name: nura-bio-track-news-archive
  slug: nura-bio-track-news-archive
slug: nura-bio
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Neuroscience
- Neurodegeneration
- Drug Discovery
- Life Sciences
- Clinical Trials
- Rare Disease
- Small Molecule Therapeutics
- content-api
website: https://nurabio.com/
---
